Diagonal Bio Balance Sheet Health
Financial Health criteria checks 5/6
Diagonal Bio has a total shareholder equity of SEK18.3M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK28.5M and SEK10.3M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr1.86m |
Equity | kr18.26m |
Total liabilities | kr10.26m |
Total assets | kr28.52m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 9F1's short term assets (SEK4.2M) do not cover its short term liabilities (SEK10.3M).
Long Term Liabilities: 9F1 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 9F1 is debt free.
Reducing Debt: 9F1 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 9F1 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 9F1 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 16.2% per year.